Atlas Trials

A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients

Clinical trial NCT05198817 · UNKNOWN

Trial details

NCT number
NCT05198817
Sponsor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Malignant Tumors
Start date
2022-02-22
Primary completion
2023-01-31
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.